{"id":"https://openalex.org/W1630772525","doi":"https://doi.org/10.1111/bdi.12003","title":"Family history of alcohol dependence and antidepressant response to an N\u2010methyl\u2010D\u2010aspartate antagonist in bipolar depression","display_name":"Family history of alcohol dependence and antidepressant response to an N\u2010methyl\u2010D\u2010aspartate antagonist in bipolar depression","alternate_titles":[],"publication_year":2012,"publication_date":"2012-09-14","ids":{"openalex":"https://openalex.org/W1630772525","doi":"https://doi.org/10.1111/bdi.12003","mag":"1630772525","pmid":"https://pubmed.ncbi.nlm.nih.gov/22978511","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3504126"},"language":"en","primary_location":{"id":"doi:10.1111/bdi.12003","doi":"https://doi.org/10.1111/bdi.12003","is_oa":false,"landing_page_url":"https://doi.org/10.1111/bdi.12003","pdf_url":null,"source":{"id":"https://openalex.org/S58085280","display_name":"Bipolar Disorders","issn_l":"1398-5647","issn":["1398-5647","1399-5618"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"public-domain","license_id":"https://openalex.org/licenses/public-domain","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bipolar Disorders","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1630772525"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3504126","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5088825358","display_name":"David A. Luckenbaugh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210158500","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210158500"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"David A Luckenbaugh","raw_affiliation_strings":["Experimental Therapeutics and Pathophysiology Branch, Division of Intramural Research Program, Department of Health and Human Services, National Institute of Mental Health, National Institutes of Health, Bethesda, MD 20892, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Experimental Therapeutics and Pathophysiology Branch, Division of Intramural Research Program, Department of Health and Human Services, National Institute of Mental Health, National Institutes of Health, Bethesda, MD 20892, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210158500"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033416284","display_name":"Lobna A. Ibrahim","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210158500","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210158500"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Lobna Ibrahim","raw_affiliation_strings":["Experimental Therapeutics and Pathophysiology Branch, Division of Intramural Research Program, Department of Health and Human Services, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Experimental Therapeutics and Pathophysiology Branch, Division of Intramural Research Program, Department of Health and Human Services, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210158500"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084081435","display_name":"Nancy E. Brutsch\u00e9","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210158500","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210158500"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Nancy Brutsche","raw_affiliation_strings":["Experimental Therapeutics and Pathophysiology Branch, Division of Intramural Research Program, Department of Health and Human Services, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Experimental Therapeutics and Pathophysiology Branch, Division of Intramural Research Program, Department of Health and Human Services, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210158500"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025110469","display_name":"Jose A. Franco-Chaves","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210158500","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210158500"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jose Franco\u2010Chaves","raw_affiliation_strings":["Experimental Therapeutics and Pathophysiology Branch, Division of Intramural Research Program, Department of Health and Human Services, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Experimental Therapeutics and Pathophysiology Branch, Division of Intramural Research Program, Department of Health and Human Services, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210158500"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060536519","display_name":"Daniel C. Mathews","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210158500","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210158500"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Daniel Mathews","raw_affiliation_strings":["Experimental Therapeutics and Pathophysiology Branch, Division of Intramural Research Program, Department of Health and Human Services, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Experimental Therapeutics and Pathophysiology Branch, Division of Intramural Research Program, Department of Health and Human Services, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210158500"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055760286","display_name":"Craig A. Marquardt","orcid":"https://orcid.org/0000-0003-2714-6168","observed_orcids":["https://orcid.org/0000-0003-2714-6168"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210158500","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210158500"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Craig A Marquardt","raw_affiliation_strings":["Experimental Therapeutics and Pathophysiology Branch, Division of Intramural Research Program, Department of Health and Human Services, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Experimental Therapeutics and Pathophysiology Branch, Division of Intramural Research Program, Department of Health and Human Services, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210158500"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087876962","display_name":"Christy N. Cassarly","orcid":"https://orcid.org/0000-0002-0304-9833","observed_orcids":["https://orcid.org/0000-0002-0304-9833"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210158500","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210158500"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Christy Cassarly","raw_affiliation_strings":["Experimental Therapeutics and Pathophysiology Branch, Division of Intramural Research Program, Department of Health and Human Services, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Experimental Therapeutics and Pathophysiology Branch, Division of Intramural Research Program, Department of Health and Human Services, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210158500"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5086133175","display_name":"Carlos A. Zarate","orcid":"https://orcid.org/0000-0003-4442-7412","observed_orcids":["https://orcid.org/0000-0003-4442-7412"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210158500","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210158500"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Carlos A Zarate","raw_affiliation_strings":["Experimental Therapeutics and Pathophysiology Branch, Division of Intramural Research Program, Department of Health and Human Services, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Experimental Therapeutics and Pathophysiology Branch, Division of Intramural Research Program, Department of Health and Human Services, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210158500"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5086133175"],"corresponding_institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210158500"],"apc_list":{"value":4730,"currency":"USD","value_usd":4730},"apc_paid":null,"fwci":6.8616,"has_fulltext":false,"cited_by_count":74,"citation_normalized_percentile":{"value":0.97555211,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"14","issue":"8","first_page":"880","last_page":"887"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.8804000020027161,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.8804000020027161,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10854","display_name":"Bipolar Disorder and Treatment","score":0.11819999665021896,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11921","display_name":"Electroconvulsive Therapy Studies","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/family-history-of-alcoholism","display_name":"family history of alcoholism","score":0.8600000143051147},{"id":"https://openalex.org/keywords/bipolar-depression","display_name":"bipolar depression","score":0.8019999861717224},{"id":"https://openalex.org/keywords/ketamine","display_name":"ketamine","score":0.9860000014305115},{"id":"https://openalex.org/keywords/nmda-receptor-antagonist","display_name":"NMDA receptor antagonists","score":0.8519999980926514},{"id":"https://openalex.org/keywords/antidepressant-response","display_name":"antidepressant response","score":0.9909999966621399},{"id":"https://openalex.org/keywords/psychotomimetic-effects","display_name":"psychotomimetic effects","score":0.7900000214576721},{"id":"https://openalex.org/keywords/dissociation","display_name":"dissociation","score":0.9670000076293945},{"id":"https://openalex.org/keywords/lithium","display_name":"lithium","score":0.37400001287460327},{"id":"https://openalex.org/keywords/valproic-acid","display_name":"valproic acid","score":0.9440000057220459},{"id":"https://openalex.org/keywords/genetic-susceptibility-to-alcoholism","display_name":"genetic susceptibility to alcoholism","score":0.41100001335144043}],"concepts":[{"id":"https://openalex.org/C2776174506","wikidata":"https://www.wikidata.org/wiki/Q131755","display_name":"Bipolar disorder","level":3,"score":0.6605894565582275},{"id":"https://openalex.org/C2778807096","wikidata":"https://www.wikidata.org/wiki/Q900394","display_name":"Dissociative","level":2,"score":0.614418625831604},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.5739386677742004},{"id":"https://openalex.org/C2780051608","wikidata":"https://www.wikidata.org/wiki/Q42844","display_name":"Major depressive disorder","level":3,"score":0.5567074418067932},{"id":"https://openalex.org/C2780795376","wikidata":"https://www.wikidata.org/wiki/Q243547","display_name":"Ketamine","level":2,"score":0.5249742865562439},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.5162774920463562},{"id":"https://openalex.org/C2776867660","wikidata":"https://www.wikidata.org/wiki/Q1814941","display_name":"Depression (economics)","level":2,"score":0.4525354504585266},{"id":"https://openalex.org/C2779727114","wikidata":"https://www.wikidata.org/wiki/Q170082","display_name":"Psychosis","level":2,"score":0.4452294111251831},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.4416426718235016},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.36437150835990906},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3429569900035858},{"id":"https://openalex.org/C2778541603","wikidata":"https://www.wikidata.org/wiki/Q152763","display_name":"Lithium (medication)","level":2,"score":0.23216134309768677},{"id":"https://openalex.org/C169900460","wikidata":"https://www.wikidata.org/wiki/Q2200417","display_name":"Cognition","level":2,"score":0.1201520562171936},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.0},{"id":"https://openalex.org/C139719470","wikidata":"https://www.wikidata.org/wiki/Q39680","display_name":"Macroeconomics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000437","descriptor_name":"Alcoholism","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D000437","descriptor_name":"Alcoholism","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D000437","descriptor_name":"Alcoholism","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001714","descriptor_name":"Bipolar Disorder","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D001714","descriptor_name":"Bipolar Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007262","descriptor_name":"Infusions, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007649","descriptor_name":"Ketamine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010555","descriptor_name":"Personality Inventory","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011569","descriptor_name":"Psychiatric Status Rating Scales","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014635","descriptor_name":"Valproic Acid","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D016014","descriptor_name":"Linear Models","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018592","descriptor_name":"Cross-Over Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018691","descriptor_name":"Excitatory Amino Acid Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1111/bdi.12003","doi":"https://doi.org/10.1111/bdi.12003","is_oa":false,"landing_page_url":"https://doi.org/10.1111/bdi.12003","pdf_url":null,"source":{"id":"https://openalex.org/S58085280","display_name":"Bipolar Disorders","issn_l":"1398-5647","issn":["1398-5647","1399-5618"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"public-domain","license_id":"https://openalex.org/licenses/public-domain","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bipolar Disorders","raw_type":"journal-article"},{"id":"pmid:22978511","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22978511","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bipolar disorders","raw_type":"Journal Article"},{"id":"pmh:oai:europepmc.org:2830399","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3504126","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:3504126","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3504126/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Bipolar Disord","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:europepmc.org:2830399","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3504126","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[{"id":"https://openalex.org/G9000891552","display_name":"Glutamatergic Modulators for Rapid and Sustained Antidepressant Effect","funder_award_id":"ZIAMH002857","funder_id":"https://openalex.org/F4320337346","funder_display_name":"National Institute of Mental Health"},{"id":"https://openalex.org/G9000905698","display_name":"Neurobiology and Target Validation of Novel Therapeutic Agents in Mood Disorders","funder_award_id":"ZIAMH002927","funder_id":"https://openalex.org/F4320337346","funder_display_name":"National Institute of Mental Health"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337346","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":30,"referenced_works":["https://openalex.org/W1547568333","https://openalex.org/W1993254026","https://openalex.org/W1993300625","https://openalex.org/W2000388202","https://openalex.org/W2002476212","https://openalex.org/W2003982930","https://openalex.org/W2012578058","https://openalex.org/W2019754485","https://openalex.org/W2020844317","https://openalex.org/W2042377182","https://openalex.org/W2042757454","https://openalex.org/W2051810836","https://openalex.org/W2058392863","https://openalex.org/W2067227935","https://openalex.org/W2069444651","https://openalex.org/W2077042793","https://openalex.org/W2080135883","https://openalex.org/W2097857685","https://openalex.org/W2108403304","https://openalex.org/W2114613490","https://openalex.org/W2119857283","https://openalex.org/W2134075154","https://openalex.org/W2145141773","https://openalex.org/W2146833432","https://openalex.org/W2157040702","https://openalex.org/W2157143899","https://openalex.org/W2160070901","https://openalex.org/W2160916899","https://openalex.org/W2323757316","https://openalex.org/W4232999601"],"related_works":["https://openalex.org/W1993300625","https://openalex.org/W2134075154","https://openalex.org/W2184926746","https://openalex.org/W4396238550","https://openalex.org/W2005055479","https://openalex.org/W4414927726","https://openalex.org/W7214794305","https://openalex.org/W2970898081","https://openalex.org/W2108403304"],"abstract_inverted_index":{"Luckenbaugh":[0],"DA,":[1],"Ibrahim":[2],"L,":[3],"Brutsche":[4],"N,":[5],"Franco\u2010Chaves":[6],"J,":[7],"Mathews":[8],"D,":[9],"Marquardt":[10],"CA,":[11],"Cassarly":[12],"C,":[13],"Zarate":[14],"CA":[15],"Jr.":[16],"Family":[17,288],"history":[18,87,108,289],"of":[19,88,109,166,171,232,290,300],"alcohol":[20,89,110,229],"dependence":[21,90,111],"and":[22,46,58,123,190,193,201,235,265],"antidepressant":[23,68,122,280],"response":[24,281],"to":[25,104,269,275,282],"an":[26,294],"N\u2010methyl\u2010d\u2010aspartate":[27,61],"antagonist":[28],"in":[29,48,52,70,97,126,284,297],"bipolar":[30,78,129,143],"depression.":[31,79,130,304],"Bipolar":[32],"Disord":[33],"2012:":[34],"14:":[35],"880\u2013887.":[36],"Published":[37],"2012.":[38],"This":[39,115],"article":[40],"is":[41,47],"a":[42,84,161,167,277],"U.S.":[43],"Government":[44],"work":[45],"the":[49,53,298],"public":[50],"domain":[51],"USA.":[54],"Objectives:":[55],"Both":[56],"ketamine":[57,101,172,242,283],"ethanol":[59],"are":[60],"(NMDA)":[62],"receptor":[63],"antagonists.":[64],"Ketamine":[65],"has":[66],"rapid":[67],"properties":[69],"major":[71],"depressive":[72,98],"disorder":[73,144],"(MDD)":[74],"as":[75,77,218],"well":[76],"In":[80,257],"individuals":[81,105,127,285],"with":[82,94,128,141,176,228,245,260,286],"MDD,":[83],"positive":[85],"family":[86,107],"(FHP)":[91],"was":[92,112,136,208],"associated":[93],"greater":[95,249],"improvement":[96,250],"symptoms":[99],"after":[100],"administration":[102],"compared":[103,268],"whose":[106],"negative":[113],"(FHN).":[114],"study":[116],"investigated":[117],"whether":[118],"FHP":[119,219,246,261,273],"influences":[120],"ketamine\u2019s":[121],"perceptual":[124],"effects":[125],"Methods:":[131],"A":[132],"post":[133],"hoc":[134],"analysis":[135],"conducted":[137],"on":[138,251],"33":[139],"subjects":[140,158,244],"DSM\u2013IV":[142],"(BD)":[145],"type":[146],"I":[147],"or":[148,178],"II":[149],"depression":[150],"pooled":[151],"from":[152],"two":[153],"previously":[154],"published":[155],"studies.":[156],"All":[157],"had":[159,262],"undergone":[160],"double\u2010blind,":[162],"randomized,":[163],"crossover":[164],"trial":[165],"single":[168],"intravenous":[169],"infusion":[170],"(0.5":[173],"mg/kg)":[174],"combined":[175],"lithium":[177],"valproate":[179],"therapy.":[180],"Subjects":[181],"were":[182,216,237],"rated":[183],"at":[184,186,194,223],"baseline;":[185],"40,":[187],"80,":[188],"120,":[189],"230":[191],"min;":[192],"days":[195],"1,":[196],"2,":[197],"3,":[198],"7,":[199],"10,":[200],"14":[202],"post\u2010infusion.":[203],"The":[204],"primary":[205],"outcome":[206],"measure":[207],"Montgomery\u2010\u00c5sberg":[209],"Depression":[210],"Rating":[211],"Scale":[212],"(MADRS)":[213],"scores.":[214],"Patients":[215],"categorized":[217],"when":[220],"they":[221],"reported":[222],"least":[224],"one":[225],"first\u2010degree":[226],"relative":[227],"dependence.":[230],"Measures":[231],"psychosis,":[233],"dissociation,":[234],"dysphoria":[236],"also":[238],"collected.":[239],"Results:":[240],"After":[241],"infusion,":[243],"showed":[247],"significantly":[248],"MADRS":[252],"scores":[253,267],"than":[254],"FHN":[255,270],"subjects.":[256],"addition,":[258],"patients":[259],"attenuated":[263],"psychotomimetic":[264],"dissociative":[266],"patients.":[271],"Conclusions:":[272],"appears":[274],"predict":[276],"more":[278],"sustained":[279],"BD.":[287],"alcoholism":[291],"may":[292],"be":[293],"important":[295],"consideration":[296],"development":[299],"glutamatergic\u2010based":[301],"therapies":[302],"for":[303]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1630772525","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":9},{"year":2015,"cited_by_count":11},{"year":2014,"cited_by_count":15},{"year":2013,"cited_by_count":7}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
